Technology

CaseMark Secures $1.7 Million Seed Funding Led by Gradient Ventures to Revolutionize Legal Workflows with Generative AI

Published

2 years ago

June 4, 2024

PORTLAND, Ore., June 4, 2024 /PRNewswire/ — CaseMark AI, a pioneer in legal generative AI workflows, today announced the closing of a $1.7 million seed funding round led by Gradient Ventures, Google’s AI-focused seed fund. Additional participation came from Rex Salisbury‘s Cambrian, Ride Home AI Fund and Alumni Ventures. The funding will drive the company’s mission to help legal professionals benefit from the efficiency and productivity of generative AI.

CaseMark’s AI-powered legal workflows address automating time-consuming tasks like document summarization, research, and legal analysis. This frees up valuable time for legal professionals to focus on high-value activities such as client strategy and casework.

CaseMark’s platform is modular, web-based, and easy-to-deploy. Unlike legacy legal tech, it seamlessly integrates into existing legal workflows such as deposition summaries or discovery responses, minimizing disruption and maximizing user adoption. The built-in chat tool allows legal professionals to query their case content in a secure, privacy first environment.

“We’re the AI easy button that won’t get attorneys in trouble,” said Scott Kveton, CEO of CaseMark. “Hours spent summarizing take minutes now. That time saved can be reclaimed to work on legal strategy,” said Kveton, highlighting the platform’s efficiency gains.

“The rise of generative AI is transforming the legal landscape. Attorneys are now leveraging AI tools to sift through vast amounts of documents and automate time-consuming tasks like summarizing lengthy court transcripts. Casemark is at the forefront of this movement, offering an innovative solution for quickly and accurately generating summaries of depositions, cases, and trials,” said Denise Teng, Investor at Gradient Ventures. “Casemark’s platform has the potential to streamline legal work, making it more efficient and cost-effective for everyone from solo practitioners, large law firms to legal tech companies. We’re proud to support Scott and his team as they redefine legal tech.”

“For generative AI to succeed in legal workflows, it needs to perform reliably and cost efficiently. With CaseMark’s LLM-agnostic architecture and mixture-of-experts approach, they can deliver best-in-class results at a fraction of the cost of their well-funded competitors. It’s game on.” stated Chris Messina, inventor of the hashtag and GP at the Ride Home AI Fund.

The seed funding will accelerate CaseMark’s product development, expand its team of AI and legal experts, and drive adoption of its AI-powered legal workflows among law firms, legaltech companies, court reporting and litigation services firms.

“CaseMark has demonstrated incredible speed in bringing a high quality product to market, delivering real value for their clients. I look forward to seeing how continued enhancements in underlying models allows the team to do even more.” said Rex Salisbury.

The CaseMark Workflow API enables access to all of CaseMark’s AI-powered workflows via a white-label integration for legal tech companies and litigation support firms. Companies can leverage the AI-as-infrastructure service provided by CaseMark to increase time-to-market and maximize revenue for the most common attorney use cases.

ABOUT GRADIENT VENTURES
Gradient Ventures has been investing at the forefront of artificial intelligence since 2017. We are led by former founders, technical experts, and domain specialists, who know how to take an idea to product-market-fit and beyond. Gradient Ventures is headquartered in the San Francisco Bay Area. For more information, visit www.gradient.com.

ABOUT CASEMARK
CaseMark is a pioneer in the legaltech industry, dedicated to transforming the way legal professionals work. Our AI-driven workflow platform streamlines document creation, research, and workflow management for law firms, litigators, and support services. With a focus on privacy, security, and innovation, CaseMark empowers legal professionals to maximize efficiency and deliver exceptional outcomes for their clients. Learn more at www.casemark.ai.

View original content to download multimedia:https://www.prnewswire.com/news-releases/casemark-secures-1-7-million-seed-funding-led-by-gradient-ventures-to-revolutionize-legal-workflows-with-generative-ai-302161963.html

SOURCE CaseMark AI, Inc.

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

52 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

52 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

52 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated